CEUS LI-RADS v2017分类与早期肝细胞癌治疗后结局的相关性
回顾性纳入272例高危且临床或病理确诊的单发肝细胞癌患者,按CEUS LI-RADS v2017分为LR 3-5与LR-M,比较初始治疗(切除或射频消融)后的无复发生存和总生存。LR-M患者RFS和OS更差,手术切除在LR-M中可能更有效;LI-RADS分类与治疗方式独立相关。
要点
- 快速廓清是判定LR-M的关键征象,LR-M患者预后更差。
- LR 3-5患者总生存优于LR-M(88.6个月 vs 74.2个月)。
- 射频消融患者中LR 3-5的OS和RFS显著优于LR-M。
核心结论
- LR-M分类的HCC患者RFS和OS更差,手术切除可能对此类患者更有效。
研究设计与样本
- 患者按BCLC分期系统接受初始切除或射频消融治疗,按CEUS LI-RADS v2017分为LR 3-5与LR-M两组。
- 采用Kaplan-Meier曲线、log-rank检验和Cox比例风险模型比较RFS和OS。
诊断标准与关键数值
- 快速廓清是判定结节为LR-M的关键决定因素。
- LR 3-5组中位OS为88.6个月,LR-M组为74.2个月(p=0.017)。
- 治疗方式和LI-RADS分类与OS和RFS独立相关(p<0.05)。
临床应用与阅片要点
- 阅片时应关注快速廓清征象,据此区分LR-M与LR 3-5,辅助预后判断。
- 对LR-M患者,手术切除可能较射频消融带来更长的OS和RFS。
- 在射频消融患者中,LR 3-5的OS和RFS显著优于LR-M,提示分类可辅助治疗决策。
局限性
- 回顾性研究设计。
- 单中心研究。
- 样本量272例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate correlation between contrast-enhanced ultrasonography Liver Imaging Reporting and Data System (CEUS LI-RADS; v. 2017) categories (LR 3-5 vs LR-M) and outcomes in patients with early-stage hepatocellular carcinoma (HCC) after initial therapy.
METHODS: In this retrospective study, 272 patients with high risks for HCC and solitary clinically or pathologically confirmed HCC were identified between January 2010 and December 2015. Patients were initially treated by resection and radiofrequency ablation (RFA) according to the Barcelona Clinic Liver Cancer staging system and were followed up until December 31, 2018. Recurrence-free survival (RFS) and overall survival (OS) were compared between nodules assigned as LR 3-5 or LR M according to CEUS LI-RADS v. 2017 by using the Kaplan-Meier curve, log-rank test, and Cox proportional hazard model.
RESULTS: Early washout is the key determinating whether a nodule is classed as LR-M. Treatment procedures and LI-RADS category showed an independent correlation with OS and RFS (p < 0.05). LR 3-5 category were more correlated with better OS (88.6 months and 74.2 months, respectively; p = 0.017) compared with LR-M. Surgical resection demonstrated longer OS and RFS than RFA in LR-M patients and longer OS in LR 3-5 patients (p < 0.05). Besides, there was no significantly difference in OS and RFS between two categories in resection (p > 0.05), while for patients treated with RFA, LR 3-5 patients showed significant longer OS and RFS than LR-M patients (p < 0.05).
CONCLUSION: Patients with HCC assigned as LR-M showed worse RFS and OS and surgical resection tended to be a more effective treatment for these patients.
ADVANCES IN KNOWLEDGE: Putting forward a theory that CEUS LI-RADS categories could independently predict the outcome for patients with solitary HCC at early-stage after initial treatment.
引用
- Hu, Yan, Yun, et al. Contrast-enhanced ultrasound liver imaging reporting and data system v2017: patient outcomes after treatment for early-stage hepatocellular carcinoma nodules with category 3-5 and category M. Br J Radiol. 2023. PMID: 37066834. doi:10.1259/bjr.20220492
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。